Microglial CD206 Gene Has Potential as a State Marker of Bipolar Disorder

Masahiro Ohgidani1, Takahiro A Kato2, Yoshinori Haraguchi3

  • 1Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University , Fukuoka , Japan.

Frontiers in Immunology
|January 26, 2017
PubMed

Insights

Microglia immune cell profiles differ between manic and depressive states in bipolar disorder. CD206 gene expression, a marker for M2 microglia, was lower during manic episodes, suggesting a role for immune cell shifts in bipolar disorder.

Area of Science:

  • Neuroscience
  • Immunology
  • Psychiatry

Background:

  • The precise mechanisms underlying the manic-depressive states in bipolar disorder remain unclear.
  • Microglia, the brain's immune cells, are implicated in neuroinflammation and have shown overactivation in bipolar disorder patients.
  • A novel technique allows for the induction of microglia-like (iMG) cells from peripheral blood monocytes.

Purpose of the Study:

  • To investigate the potential role of immunological shifts in microglia in the transition between manic and depressive states in bipolar disorder.
  • To analyze gene expression patterns in induced microglia-like cells from bipolar disorder patients during different mood states.

Main Methods:

  • Induced microglia-like (iMG) cells were generated from peripheral blood monocytes of three rapid cycling bipolar disorder patients.
  • Gene profiling of iMG cells was performed during both manic and depressive states for each patient.
  • Analysis focused on identifying differential gene expression patterns related to microglial states (M1/M2) and specific markers like CD206.

Main Results:

  • Gene profiling patterns of iMG cells differed significantly between manic and depressive states.
  • While M1 microglia dominance was observed in mania for one patient, patterns varied across individuals.
  • CD206, an M2 microglia marker, was consistently downregulated during the manic state in all three patients.

Conclusions:

  • This study provides the first evidence for the dynamic shift in microglial M1/M2 characteristics, particularly CD206 expression, between manic and depressive states in bipolar disorder.
  • These findings highlight the potential involvement of microglial immune responses in the pathophysiology of bipolar disorder.
  • Further translational research is warranted to elucidate the specific roles of microglia in the biological mechanisms of bipolar disorder.